ANTI-VEGF THERAPY SWITCHING IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION Insights from Automated Volumetric Retinal Fluid Analysis
Dor, Omer; Cohen, May; Shahar-Gonen, Marganit; Loewenstein, Anat; Peto, Tunde; Wright, David; Shor, Reut; Havilio, Moshe; Benyamini, Gidi; Wen, Qing; Shomron, Noam; Zur, Dinah.png)
Share.png)
Save LONG-TERM EFFICACY AND SAFETY OF PHOTOBIOMODULATION IN DRY AGE-RELATED MACULAR DEGENERATION (LIGHTSITE III: 24-MONTH ANALYSIS)Jaffe, Glenn J.; Boyer, David; Hu, Allen; Warrow, David; Xavier, Samantha; Gonzalez, Victor; Lad, Eleonora; Rosen, Richard B.; Do, Diana V.; Schneiderman, Todd; Ho, Allen C.; Munk, Marion R.; Tedford, Stephanie E.; Croissant, Cindy L.; Ruckert, Rene; Lavin, Philip T.; Tedford, Clark E. Share Save EFFICACY AND SAFETY OF THE PROPOSED BIOSIMILAR AFLIBERCEPT, SDZ-AFL, IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION 52-Week Results From the Phase 3 Mylight Study (vol 44 , pg 1704 , 2024 )Bordon, Arnaldo F.; Kaiser, Peter K.; Wolf, Armin; Cen, Liyi; Heyn, Jens; Urosevic, Dragan; Dodeller, Francis; Allmannsberger, Lisa; Silva, Rufino Share Save 
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
